BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 24845231)

  • 1. Targeting the disordered C terminus of PTP1B with an allosteric inhibitor.
    Krishnan N; Koveal D; Miller DH; Xue B; Akshinthala SD; Kragelj J; Jensen MR; Gauss CM; Page R; Blackledge M; Muthuswamy SK; Peti W; Tonks NK
    Nat Chem Biol; 2014 Jul; 10(7):558-66. PubMed ID: 24845231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional properties of Claramine: a novel PTP1B inhibitor and insulin-mimetic compound.
    Qin Z; Pandey NR; Zhou X; Stewart CA; Hari A; Huang H; Stewart AF; Brunel JM; Chen HH
    Biochem Biophys Res Commun; 2015 Feb; 458(1):21-7. PubMed ID: 25623533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial protein-tyrosine phosphatase 1B contributes to the induction of mammary tumors by HER2/Neu but is not essential for tumor maintenance.
    Balavenkatraman KK; Aceto N; Britschgi A; Mueller U; Bence KK; Neel BG; Bentires-Alj M
    Mol Cancer Res; 2011 Oct; 9(10):1377-84. PubMed ID: 21849469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective binding modes and allosteric inhibitory effects of lupane triterpenes on protein tyrosine phosphatase 1B.
    Jin T; Yu H; Huang XF
    Sci Rep; 2016 Feb; 6():20766. PubMed ID: 26865097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-tyrosine phosphatase 1B antagonized signaling by insulin-like growth factor-1 receptor and kinase BRK/PTK6 in ovarian cancer cells.
    Fan G; Lin G; Lucito R; Tonks NK
    J Biol Chem; 2013 Aug; 288(34):24923-34. PubMed ID: 23814047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of small peptide compounds, molecular docking, and inhibitory activity evaluation against phosphatases PTP1B and SHP2.
    Kostrzewa T; Sahu KK; Gorska-Ponikowska M; Tuszynski JA; Kuban-Jankowska A
    Drug Des Devel Ther; 2018; 12():4139-4147. PubMed ID: 30584278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective Covalent Inhibition of "Allosteric Cys121" Distort the Binding of PTP1B Enzyme: A Novel Therapeutic Approach for Cancer Treatment.
    Khan S; Bjij I; Soliman MES
    Cell Biochem Biophys; 2019 Sep; 77(3):203-211. PubMed ID: 31446553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein tyrosine phosphatase 1B regulates endothelial endoplasmic reticulum stress; role in endothelial dysfunction.
    Thiebaut PA; Delile E; Coquerel D; Brunel JM; Renet S; Tamion F; Richard V
    Vascul Pharmacol; 2018 Oct; 109():36-44. PubMed ID: 29894845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular dynamics approach to probe the allosteric inhibition of PTP1B by chlorogenic and cichoric acid.
    Baskaran SK; Goswami N; Selvaraj S; Muthusamy VS; Lakshmi BS
    J Chem Inf Model; 2012 Aug; 52(8):2004-12. PubMed ID: 22747429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico investigations on the binding efficacy and allosteric mechanism of six different natural product compounds towards PTP1B inhibition through docking and molecular dynamics simulations.
    SarathKumar B; Lakshmi BS
    J Mol Model; 2019 Aug; 25(9):272. PubMed ID: 31451955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis.
    Julien SG; Dubé N; Read M; Penney J; Paquet M; Han Y; Kennedy BP; Muller WJ; Tremblay ML
    Nat Genet; 2007 Mar; 39(3):338-46. PubMed ID: 17259984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and identification of potential PTP1B allosteric inhibitors using in silico and in vitro approaches.
    Shinde RN; Kumar GS; Eqbal S; Sobhia ME
    PLoS One; 2018; 13(6):e0199020. PubMed ID: 29912965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural analysis of protein tyrosine phosphatase 1B reveals potentially druggable allosteric binding sites.
    Kumar AP; Nguyen MN; Verma C; Lukman S
    Proteins; 2018 Mar; 86(3):301-321. PubMed ID: 29235148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketamine's schizophrenia-like effects are prevented by targeting PTP1B.
    Qin Z; Zhang L; Zasloff MA; Stewart AFR; Chen HH
    Neurobiol Dis; 2021 Jul; 155():105397. PubMed ID: 34015491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covalent Allosteric Inactivation of Protein Tyrosine Phosphatase 1B (PTP1B) by an Inhibitor-Electrophile Conjugate.
    Punthasee P; Laciak AR; Cummings AH; Ruddraraju KV; Lewis SM; Hillebrand R; Singh H; Tanner JJ; Gates KS
    Biochemistry; 2017 Apr; 56(14):2051-2060. PubMed ID: 28345882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native dynamics and allosteric responses in PTP1B probed by high-resolution HDX-MS.
    Woods VA; Abzalimov RR; Keedy DA
    Protein Sci; 2024 Jun; 33(6):e5024. PubMed ID: 38801229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.
    Ricke KM; Cruz SA; Qin Z; Farrokhi K; Sharmin F; Zhang L; Zasloff MA; Stewart AFR; Chen HH
    J Neurosci; 2020 Feb; 40(7):1581-1593. PubMed ID: 31915254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer.
    Bentires-Alj M; Neel BG
    Cancer Res; 2007 Mar; 67(6):2420-4. PubMed ID: 17347513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine phosphatase PTP1B impairs presynaptic NMDA receptor-mediated plasticity in a mouse model of Alzheimer's disease.
    Zhang L; Qin Z; Sharmin F; Lin W; Ricke KM; Zasloff MA; Stewart AFR; Chen HH
    Neurobiol Dis; 2021 Aug; 156():105402. PubMed ID: 34044147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of PTP1B by trodusquemine (MSI-1436) causes fat-specific weight loss in diet-induced obese mice.
    Lantz KA; Hart SG; Planey SL; Roitman MF; Ruiz-White IA; Wolfe HR; McLane MP
    Obesity (Silver Spring); 2010 Aug; 18(8):1516-23. PubMed ID: 20075852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.